Correlation Between Pfizer and IShares GNMA

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Pfizer and IShares GNMA at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pfizer and IShares GNMA into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pfizer Inc and iShares GNMA Bond, you can compare the effects of market volatilities on Pfizer and IShares GNMA and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pfizer with a short position of IShares GNMA. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pfizer and IShares GNMA.

Diversification Opportunities for Pfizer and IShares GNMA

0.68
  Correlation Coefficient

Poor diversification

The 3 months correlation between Pfizer and IShares is 0.68. Overlapping area represents the amount of risk that can be diversified away by holding Pfizer Inc and iShares GNMA Bond in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on iShares GNMA Bond and Pfizer is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pfizer Inc are associated (or correlated) with IShares GNMA. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of iShares GNMA Bond has no effect on the direction of Pfizer i.e., Pfizer and IShares GNMA go up and down completely randomly.

Pair Corralation between Pfizer and IShares GNMA

Considering the 90-day investment horizon Pfizer Inc is expected to under-perform the IShares GNMA. In addition to that, Pfizer is 4.05 times more volatile than iShares GNMA Bond. It trades about -0.16 of its total potential returns per unit of risk. iShares GNMA Bond is currently generating about 0.15 per unit of volatility. If you would invest  4,332  in iShares GNMA Bond on September 1, 2024 and sell it today you would earn a total of  60.00  from holding iShares GNMA Bond or generate 1.39% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy95.45%
ValuesDaily Returns

Pfizer Inc  vs.  iShares GNMA Bond

 Performance 
       Timeline  
Pfizer Inc 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Pfizer Inc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound technical and fundamental indicators, Pfizer is not utilizing all of its potentials. The current stock price tumult, may contribute to shorter-term losses for the shareholders.
iShares GNMA Bond 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days iShares GNMA Bond has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong primary indicators, IShares GNMA is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Pfizer and IShares GNMA Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Pfizer and IShares GNMA

The main advantage of trading using opposite Pfizer and IShares GNMA positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pfizer position performs unexpectedly, IShares GNMA can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in IShares GNMA will offset losses from the drop in IShares GNMA's long position.
The idea behind Pfizer Inc and iShares GNMA Bond pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.

Other Complementary Tools

USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Fundamental Analysis
View fundamental data based on most recent published financial statements